Inactive Instrument

GenMark Diagnostics, Inc.

Equities

GNMK

US3723091043

Advanced Medical Equipment & Technology

GenMark Diagnostics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2014

January 12, 2015 at 09:05 pm

GenMark Diagnostics, Inc. provided revenue guidance for the fourth quarter and full year of 2014. For the fourth quarter, the company expects fourth quarter 2014 revenue of $9.8 million, an increase of 52% over the prior year period.

Full year 2014 revenue is expected to be $30.6 million, an increase of 59% against 2013 base business revenue, which excludes former customer NMTC.

Latest news about GenMark Diagnostics, Inc.

GenMark Diagnostics, Inc. Announces Executive Changes	22/04/21	CI
Roche : Secures 83% Acceptances In $1.8 Billion Tender Offer For GenMark Diagnostics	22/04/21	MT
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Global BMI Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P TMI Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Healthcare Equipment Select Industry Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Completeness Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Comp Growth Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Growth Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Growth Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Growth Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Dynamic Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Dynamic Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth-Dynamic Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth-Dynamic Index	22/04/21	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from NASDAQ Composite Index	22/04/21	CI
Roche Holding AG completed the acquisition of GenMark Diagnostics, Inc..	20/04/21	CI
Insider Trends: GenMark Diagnostics Insider Exercises Options Extending 90-Day Buying Trend	16/04/21	MT
Roche : U.S. lab products provider Avantor to buy Germany's Ritter for $1.1 bln	12/04/21	RE

Chart GenMark Diagnostics, Inc.

Duration

Period

More charts

Company Profile

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+4.77%	213B
DANAHER CORPORATION	+9.26%	188B
INTUITIVE SURGICAL, INC.	+31.52%	157B
BOSTON SCIENTIFIC CORPORATION	+33.54%	113B
SIEMENS HEALTHINEERS AG	+4.14%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+21.80%	55.17B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.51%	49.1B
AGILENT TECHNOLOGIES, INC.	-4.41%	38.83B
GE HEALTHCARE TECHNOLOGIES INC.	+0.92%	35.6B

Other Advanced Medical Equipment & Technology